✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
This article presents a case demonstrating that valproic acid, which is widely used in the treatment of bipolar disorder, can lead to hyperammonemic encephalopathy, a rare but potentially serious adverse effect.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:This article presents a case demonstrating that valproic acid, which is widely used in the treatment of bipolar disorder, can lead to hyperammonemic encephalopathy, a rare but potentially serious adverse effect.
📊
Key Findings & Data:This article presents a case demonstrating that valproic acid, which is widely used in the treatment of bipolar disorder, can lead to hyperammonemic encephalopathy, a rare but potentially serious adverse effect.
💡
Conclusion & Impact:This article presents a case demonstrating that valproic acid, which is widely used in the treatment of bipolar disorder, can lead to hyperammonemic encephalopathy, a rare but potentially serious adverse effect.
🔬Design:Editöre Mektup
📍Scope:Comprehensive Sample
⚙️Variables:Hiperammonemik · Ensefalopati · Valproik asit.
Abstract
This article presents a case demonstrating that valproic acid, which is widely used in the treatment of bipolar disorder, can lead to hyperammonemic encephalopathy, a rare but potentially serious adverse effect.
Özet
Bu yazıda, bipolar duygudurum bozukluğu tedavisinde yaygın olarak kullanılan valproik asidin, nadir ancak potansiyel olarak ciddi bir yan etkisi olan hiperamonyemik ensefalopatiye yol açabileceğini gösteren bir olgu sunulmaktadır.
🔖
Cite This Article
Ay, R. (2026). Valproic Acid–Induced Hyperammonemic Encephalopathy: A Case Report. Dicle Tıp Dergisi, Cilt: 53 Sayı: 3, 757–759. https://doi.org/10.5798/dicletip.2037497